Trial Profile
Clinical Phase II Study Evaluating Systemic Chemotherapy in Combination With Cetuximab as Adjuvant Treatment in Patients With Completely Surgically Resected Peritoneal Carcinomatosis of Colorectal Origin.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 01 Feb 2021
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary)
- Indications Adenocarcinoma; Carcinoma; Colorectal cancer; Peritoneal cancer
- Focus Therapeutic Use
- Acronyms COCHISE
- 05 Jan 2021 Status changed from completed to discontinued.
- 13 Apr 2017 Status changed from recruiting to completed.
- 21 Oct 2008 New trial record.